Table 2.
0–12 | 13–24 | 25–36 | 37–48 | 48- | Total | |
---|---|---|---|---|---|---|
DM following 356 TMT | 87 | 21 | 8 | 2 | 1 | 119 |
* | 24.4% | 5.9% | 2.2% | 0.6% | 0.3% | 33.4% |
** | 73.1% | 17.6% | 6.7% | 1.7% | 0.8% | 100.0% |
*** | 73.1% | 90.8% | 97.5% | 99.2% | 100.0% | |
DM following 273 BMT | 93 | 12 | 3 | 0 | 1 | 109 |
* | 34.1% | 4.4% | 1.1% | 0.0% | 0.4% | 39.9% |
** | 85.3% | 11.0% | 2.8% | 0.0% | 0.9% | 100.0% |
*** | 85.3% | 96.3% | 99.1% | 99.1% | 100.0% |
Denominators are number of total patients with each treatment; 356 with TMT and 273 with BMT.
Denominators are number of distant metastasis in each treatment; 119 with TMT and 109 with BMT.
Cumulative % of failure